Intero Biosystems Wins Startup Battlefield at TechCrunch Disrupt 2026
At the TechCrunch Disrupt 2026 event in San Francisco, Intero Biosystems was named the winner of the Startup Battlefield competition. The Denver-based startup specializes in developing human intestinal organoids for drug and compound testing before clinical trials. It offers its flagship product GastroScreen to pharmaceutical, biotech, food, and chemical companies. The final five startups were selected from a pool of 20 that represented the top 1% of over 200 applicants. The winner received $100,000 in prize money along with recognition on one of tech's most prominent startup stages. Apate, an Australian cybersecurity firm using AI to detect scams, was named runner-up. Startup Battlefield alumni have collectively raised more than $30 billion and achieved over 200 exits since the program began.
